Genedx Holdings CORP Form 4 insider transactions

GeneDx Holdings Corp. reports that President Mark A. Gardner was granted 35,441 restricted stock units on June 29, 2026.

GeneDx Holdings Corp. reports that Chief Financial Officer Kevin Feeley sold shares to cover tax obligations related to RSU vesting.

Katherine Stueland, CEO and Director of GeneDx Holdings Corp., reported the sale of 8,501 shares of Class A Common Stock to cover tax withholding obligations upon the vesting of restricted stock units.

GeneDx Holdings Corp. CFO Kevin Feeley reports on stock transactions, including RSU vesting and sale to cover tax obligations.

Katherine Stueland, CEO of GeneDx Holdings Corp., reported transactions involving Class A Common Stock and Restricted Stock Units.

Casdin Capital, LLC and Eli Casdin have increased their beneficial ownership in GeneDx Holdings Corp. through recent open market purchases.

Kevin Feeley, CFO of GeneDx Holdings Corp., reported transactions involving Class A Common Stock and Restricted Stock Units.

Casdin Capital and Eli Casdin have increased their beneficial ownership in GeneDx Holdings Corp. through a series of open market purchases.

Corvex Management LP and Keith A. Meister have increased their beneficial ownership in GeneDx Holdings Corp. through a series of open market purchases.

Keith Meister and Corvex Management have significantly increased their beneficial ownership in GeneDx Holdings Corp. through a series of open market purchases.

Casdin Capital, LLC and related entities have increased their economic exposure to GeneDx Holdings Corp. through cash-settled swap agreements.

CEO Katherine Stueland acquired 3,874 shares via RSU vesting and sold a portion to cover tax obligations.

GeneDx Holdings Corp. CFO Kevin Feeley acquired 754 shares via RSU vesting and sold 392 shares to cover tax obligations.

GeneDx Holdings Corp. CEO Katherine Stueland reported the vesting of restricted stock units and subsequent 'sell to cover' transactions to satisfy tax obligations.

GeneDx Holdings Corp.'s Chief Financial Officer, Kevin Feeley, reported the vesting of restricted stock units and subsequent sale of shares to cover tax withholding obligations.

Keith A. Meister and Corvex Management LP significantly increased their beneficial ownership in GeneDx Holdings Corp. through multiple Class A Common Stock purchases totaling 169,521 shares.

GeneDx Holdings Corp. Chief Operating Officer Bryan Dechairo received an award of 10,430 Restricted Stock Units, vesting over four years.

GeneDx Holdings Corp. CFO Kevin Feeley reported the acquisition of performance-based restricted stock units and subsequent sales to cover tax obligations.

GeneDx Holdings Corp. CEO Katherine Stueland reported the acquisition of shares from a performance-based award and subsequent sales to cover tax obligations.

GeneDx Holdings Corp.'s Chief Operating Officer, Bryan Dechairo, sold 5,961 shares of Class A Common Stock across multiple transactions on February 4, 2026, pursuant to a pre-arranged 10b5-1 trading plan.

GeneDx Holdings Corp.'s Chief Operating Officer, Bryan Dechairo, sold a portion of his Class A Common Stock to cover tax withholding obligations following the vesting of restricted stock units.

GeneDx Holdings Corp. CFO Kevin Feeley sold shares to cover tax withholding obligations related to RSU vesting.

GeneDx Holdings Corp. CEO Katherine Stueland sold 1,653 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

GeneDx Holdings Corp. CFO Kevin Feeley reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

GeneDx Holdings Corp.'s CEO, Katherine Stueland, reported the acquisition of shares from RSU vesting and subsequent sale of a portion to cover tax withholding obligations.

GeneDx Holdings Corp.'s Chief Financial Officer, Kevin Feeley, sold 1,266 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

GeneDx Holdings Corp. CEO Katherine Stueland sold 3,639 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

GeneDx Holdings Corp.'s CFO, Kevin Feeley, sold shares to cover tax withholding obligations related to vested restricted stock units.

Joshua Ruch, a Director and 10% owner of GeneDx Holdings Corp., reported the sale of 67,723 shares of Class A Common Stock across multiple transactions on November 24, 2025.

GeneDx Holdings Corp. CEO Katherine Stueland reported a pre-planned future sale of shares on October 29, 2025, to cover tax withholding obligations from restricted stock unit vesting.